Event Overview

When chronically stimulated, T cells can enter an exhausted state where they cease effector functions. This is especially important in cancer, where T cells function abnormally upon activation and can differentiate into a terminally dysfunctional state upon continued tumor exposure. In this webinar from The Scientist, Mary Philip and Benjamin Youngblood will discuss how T cell exhaustion is defined, its causes and drivers, and how it affects cell responses to immunotherapies.

Topics to be covered

  • T cell dysfunction and exhaustion in cancer
  • Using epigenetic mechanisms of T cell exhaustion to enhance immunotherapy

  • Friday, March 11, 2022

    2:30 - 4:00 PM Eastern Time 

    This webinar will also be available on-demand.

    Meet the speakers

    Mary Philip, MD, PhD
    Assistant Professor
    Department of Medicine/Division of Hematology-Oncology
    Department of Pathology, Microbiology, and Immunology
    Vanderbilt University Medical Center

    Benjamin Youngblood, PhD
    Associate Member
    Department of Immunology
    St. Jude Children’s Research Hospital

    Sponsored by








    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.